TIVC Stock Price, Tivic Health Systems, . Quote, Chart

Market Summary

USD0.51-0.08

Market Closed

-13.56%

TIVC Stock Price

View Fullscreen

TIVC RSI Chart

TIVC Valuation

Market Cap

865.0K

Price/Earnings (Trailing)

-0.1

Price/Sales (Trailing)

0.74

EV/EBITDA

0.31

Price/Free Cashflow

-0.1

TIVC Price/Sales (Trailing)

TIVC Profitability

Operating Margin

24.40%

EBT Margin

-701.02%

Return on Equity

-230.29%

Return on Assets

-159.87%

Free Cashflow Yield

-997.58%

TIVC Fundamentals

TIVC Revenue

Revenue (TTM)

1.2M

Rev. Growth (Yr)

-12.39%

Rev. Growth (Qtr)

26.6%

TIVC Earnings

Earnings (TTM)

-8.2M

Earnings Growth (Yr)

1.38%

Earnings Growth (Qtr)

-27.47%

Breaking Down TIVC Revenue

52 Week Range

0.044.01

(Low)(High)

Last 7 days

-44.9%

Last 30 days

-50.8%

Last 90 days

-52.4%

Trailing 12 Months

-96.4%

How does TIVC drawdown profile look like?

TIVC Financial Health

Current Ratio

3.32

TIVC Investor Care

Shares Dilution (1Y)

394.00%

Diluted EPS (TTM)

-14.84

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2023	1.8M	1.4M	1.2M	1.2M
2022	1.4M	1.6M	1.7M	1.8M
2021	959.3K	1.1M	1.2M	1.3M
2020	0	0	0	860.0K

Get all data in R, Python etc through our Historical Stock Data APIs

Tracking the Latest Insider Buys and Sells of Tivic Health Systems, Inc.

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Mar 12, 2024	bambach kimberly ann	acquired	-	-	7,500	interim cfo
May 16, 2022	drexler karen	sold	-	-	-15,111	-
Nov 12, 2021	ernst jennifer	acquired	-	-	28,377	chief executive officer

Which funds bought or sold TIVC recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
May 01, 2024	CONCOURSE FINANCIAL GROUP SECURITIES, INC.	sold off	-	-	-	-%
Mar 11, 2024	VANGUARD GROUP INC	new	-	86,366	86,366	-%
Feb 14, 2024	CITADEL ADVISORS LLC	sold off	-100	-28,893	-	-%
Feb 13, 2024	NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO	new	-	90.00	90.00	-%
Feb 13, 2024	GEODE CAPITAL MANAGEMENT, LLC	new	-	20,614	20,614	-%
Feb 13, 2024	Tower Research Capital LLC (TRC)	added	283	3,181	4,243	-%
Feb 12, 2024	OSAIC HOLDINGS, INC.	unchanged	-	11.00	262	-%
Feb 09, 2024	UBS Group AG	added	80.83	183	391	-%
Feb 09, 2024	WELLS FARGO & COMPANY/MN	unchanged	-	1.00	20.00	-%
Feb 09, 2024	CITIGROUP INC	sold off	-100	-1,220	-	-%

Are Funds Buying or Selling TIVC?

Are funds buying TIVC calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own TIVC

No. of Funds

Unveiling Tivic Health Systems, Inc.'s Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 09, 2024	l1 capital global opportunities master fund, ltd.	0%	0	SC 13G/A
Feb 01, 2024	bigger capital, llc	-	0	SC 13G/A
Jul 24, 2023	l1 capital global opportunities master fund, ltd.	8.8%	1e+07	SC 13G/A
Jul 17, 2023	l1 capital global opportunities master fund, ltd.	9.6%	6e+06	SC 13G
Feb 21, 2023	bigger capital fund l p	3.7%	1,102,988	SC 13G

Recent SEC filings of Tivic Health Systems, Inc.

View All Filings

Date Filed	Form Type	Document
May 09, 2024	EFFECT	EFFECT
May 08, 2024	S-1/A	Initial Public Offering
May 08, 2024	8-K	Current Report
Apr 29, 2024	S-1/A	Initial Public Offering
Mar 29, 2024	S-1	Initial Public Offering
Mar 25, 2024	8-K	Current Report
Mar 25, 2024	10-K	Annual Report
Mar 22, 2024	4	Insider Trading
Mar 22, 2024	4	Insider Trading
Mar 22, 2024	4	Insider Trading

Peers (Alternatives to Tivic Health Systems, Inc.)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
ABT	182.1B	40.3B	-6.91%	-5.44%	32.37	4.52	-2.84%	-3.08%
BDX	67.9B	19.7B	-4.40%	-6.39%	50.95	3.44	4.82%	-17.56%
ALGN	21.1B	3.9B	-15.05%	-8.09%	45.66	5.39	5.72%	46.72%
BAX	18.3B	14.9B	-16.06%	-18.00%	6.92	1.23	2.98%	207.68%
MID-CAP
ATR	9.9B	3.5B	6.22%	24.59%	31.58	2.79	6.16%	35.06%
HSIC	9.4B	12.5B	0.31%	-3.70%	24.24	0.76	-0.61%	-18.83%
BIO	7.9B	2.6B	-18.28%	-24.14%	-24.53	3.04	-6.25%	-68.62%
XRAY	5.9B	3.9B	-14.09%	-31.22%	-62.62	1.49	0.23%	91.03%
AXNX	3.4B	387.1M	-0.49%	17.89%	-215.82	8.88	30.82%	65.57%
PDCO	2.4B	6.6B	-0.94%	-	12.18	0.36	2.78%	-0.87%
SMALL-CAP
AHCO	1.2B	3.2B	-11.83%	-17.09%	-1.76	0.38	7.94%	-1661.78%
ANIK	374.6M	169.3M	-2.43%	-	-4.88	2.21	7.49%	-244.90%
ANGO	245.1M	324.0M	-12.34%	-33.15%	-1.27	0.76	-3.19%	-337.41%
APYX	57.5M	50.5M	17.69%	-50.29%	-2.52	1.14	14.25%	-10.06%
AEMD	3.1M	3.7M	-28.92%	247.06%	-0.25	0.82	5.77%	8.23%

Tivic Health Systems, Inc. News

Latest updates

Tivic Health Systems, Inc. Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

Income Statement (Quarterly)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4
Revenue	26.6%	357,000	282,000	161,000	376,000	407,500	477,000	528,000	428,000	408,500	389,000	277,000	268,000	323,000	-
Cost Of Revenue	102.3%	352,000	174,000	100,000	263,000	365,500	414,000	403,000	358,000	-	390,500	303,000	301,000	301,000	-
Gross Profit	-95.4%	5,000	108,000	61,000	113,000	42,000	63,000	125,000	70,000	-	-1,500	-26,000	-33,000	22,000	-
Operating Expenses	20.4%	2,249,000	1,868,000	2,186,000	2,229,000	2,297,500	2,647,000	3,143,000	2,311,000	-	2,290,500	1,203,000	1,022,000	1,079,000	-
S&GA Expenses	53.1%	735,000	480,000	452,000	458,000	498,500	487,000	1,125,000	684,000	-	692,000	450,000	345,000	300,000	-
R&D Expenses	6.8%	360,000	337,000	468,000	490,000	434,000	399,000	497,000	401,000	-	313,000	175,000	192,000	198,000	-
EBITDA Margin	-1.3%	-7.00	-6.92	-5.96	-4.74	-4.61	-5.30	-6.41	-6.77	-7.14	-7.81	-2.77	-3.03	-3.34	-3.73
Interest Expenses	-	-	-	-	-	500	1,000	-	1,000	-	-652,000	-1,171,000	223,000	274,000	-
Earnings Before Taxes	-	-	-	-	-	-	-	-	-	-	-	-	-	-1,356,000	-
EBT Margin	-1.2%	-7.01	-6.92	-5.97	-4.75	-4.61	-4.93	-5.28	-5.70	-6.18	-6.76	-3.14	-3.44	-3.79	-4.23
Net Income	-27.5%	-2,243,500	-1,760,000	-2,125,000	-2,116,000	-2,275,000	-2,584,000	-3,018,000	-2,240,000	-	-3,724,000	-2,320,000	-1,094,000	-1,356,000	-
Net Income Margin	-4.2%	-7.01	-6.73	-6.39	-5.58	-5.49	-4.93	-5.29	-5.70	-6.18	-6.76	-3.14	-3.44	-3.79	-4.23
Free Cashflow	1.4%	-1,811,000	-1,837,000	-2,498,000	-2,520,000	-2,219,000	-2,805,000	-1,732,000	-2,174,000	-	-	-	-	-	-

Balance Sheet

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Balance Sheet										(In Thousands)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2020Q4
Assets	-26.4%	5,157	7,007	4,596	7,101	5,875	8,208	11,026	12,694	15,036	1,531
Current Assets	-27.9%	4,652	6,455	4,000	6,482	5,306	7,594	10,372	11,998	14,289	1,497
Cash Equivalents	-34.6%	3,400	5,200	2,659	5,200	3,517	6,328	9,049	10,801	12,975	1,044
Inventory	-18.5%	756	928	988	943	863	761	833	447	429	241
Net PPE	-1.6%	122	124	124	104	12.00	15.00	13.00	16.00	11.00	19.00
Liabilities	27.0%	1,577	1,242	1,435	1,896	2,245	2,436	2,839	1,601	1,764	2,708
Current Liabilities	40.1%	1,401	1,000	1,160	1,573	1,878	2,023	2,378	1,097	1,219	1,275
Shareholder's Equity	-37.9%	3,580	5,765	3,161	5,205	3,630	5,772	8,187	11,093	13,272	-
Retained Earnings	-6.4%	-37,886	-35,600	-33,900	-31,800	-29,642	-27,400	-24,804	-21,800	-19,546	-11,052
Additional Paid-In Capital	0.1%	41,466	41,408	37,041	36,960	33,272	33,159	32,990	32,878	32,817	9,874
Shares Outstanding	0%	1,466	1,466	297	297	97.00	97.00	96.00	97.00	97.00	23.00
Float	-	-	-	3,000	-	-	-	13,000	-	-	-

Cashflow (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)														(In Thousands)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4
Cashflow From Operations	1.3%	-1,811	-1,834	-2,466	-2,400	-2,219	-2,800	-1,732	-2,168	-	-2,760	-1,644	-543	-665	-
Share Based Compensation	20.8%	58.00	48.00	81.00	84.00	112	113	112	61.00	-	16.00	23.00	8.00	10.00	-
Cashflow From Investing	-	-	-	-24.00	-94.00	-	-5.00	-	-6.00	-	-	-	-	-	-
Cashflow From Financing	-100.0%	-	4,381	-44.00	4,170	-584	56.00	-	-	-	14,887	869	1,566	221	-

Get Full Access to Grufity – and Unlimited Downloads

Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.

Try For Just $1.99

TIVC Income Statement

2023-12-31

Statements of Operations - USD ($) $ in Thousands	12 Months Ended
Statements of Operations - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Income Statement [Abstract]
Revenue	$ 1,176	$ 1,840
Cost of sales	889	1,541
Gross profit	287	299
Operating expenses:
Research and development	1,655	1,730
Sales and marketing	2,125	2,792
General and administrative	4,752	5,875
Total operating expenses	8,532	10,397
Loss from operations	(8,245)	(10,098)
Other income:
Interest income	1	2
Total other income	1	2
Net loss before income taxes	$ (8,244)	$ (10,096)
Net loss per share - basic	$ (10.4)	$ (104.32)
Net loss per share - diluted	$ (10.4)	$ (104.32)
Weighted-average number of shares - basic	793,043	96,778
Weighted-average number of shares - diluted	793,043	96,778

TIVC Balance Sheet

2023-12-31

Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Current assets
Cash and cash equivalents	$ 3,395	$ 3,517
Accounts receivable, net	174	107
Inventory, net	756	863
Deferred offering costs	0	584
Prepaid expenses and other current assets	327	235
Total current assets	4,652	5,306
Property and equipment, net	122	12
Right-of-use assets, operating lease	349	523
Other assets	34	34
Total assets	5,157	5,875
Current liabilities
Accounts payable	713	1,323
Other accrued expenses	495	392
Operating lease liability, current	193	163
Total current liabilities	1,401	1,878
Operating lease liability	176	367
Total liabilities	1,577	2,245
Commitments and contingencies (Note 6)
Stockholders' equity
Common stock, $0.0001 par value, 200,000,000 shares authorized; 1,466,092 and 96,778 shares issued and outstanding at December 31, 2023 and 2022, respectively	0	0
Additional paid in capital	41,466	33,272
Accumulated deficit	(37,886)	(29,642)
Total stockholders' equity	3,580	3,630
Total liabilities and stockholders' equity	$ 5,157	$ 5,875

About Tivic Health Systems, Inc.

Tivic Health Systems Inc. operates as a health technology company, focuses on developing and commercializing non-invasive bioelectronic medicine. Its primary product is ClearUP, a bioelectronic medicine for the treatment of sinus and nasal congestion pains. The company sells its products on direct-to-consumer channel through its own websites; and platforms, such as Amazon.com and Walmart.com, as well as to U.S. online retailers, such as BestBuy and FSAStore. Tivic Health Systems, Inc. was incorporated in 2016 and is headquartered in Hayward, California.

CEO	Ms. Jennifer Ernst
WEBSITE	https://tivichealth.com
INDUSTRY	Medical Instruments & Supplies
EMPLOYEES	11

Tivic Health Systems, Inc. Frequently Asked Questions

What is the ticker symbol for Tivic Health Systems, Inc.? What does TIVC stand for in stocks?

TIVC is the stock ticker symbol of Tivic Health Systems, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Tivic Health Systems, Inc. (TIVC)?

As of Thu May 09 2024, market cap of Tivic Health Systems, Inc. is 864.99 Thousand. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of TIVC stock?

You can check TIVC's fair value in chart for subscribers.

What is the fair value of TIVC stock?

You can check TIVC's fair value in chart for subscribers. The fair value of Tivic Health Systems, Inc. is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Tivic Health Systems, Inc. is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for TIVC so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Tivic Health Systems, Inc. a good stock to buy?

The fair value guage provides a quick view whether TIVC is over valued or under valued. Whether Tivic Health Systems, Inc. is cheap or expensive depends on the assumptions which impact Tivic Health Systems, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for TIVC.

What is Tivic Health Systems, Inc.'s Price to Earnings (PE) and Price to sales (PS) ratio?

As of Thu May 09 2024, TIVC's PE ratio (Price to Earnings) is -0.1 and Price to Sales (PS) ratio is 0.74. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. TIVC PE ratio will change depending on the future growth rate expectations of investors.